Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Aug;46(2):220–227. doi: 10.1038/bjc.1982.187

Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.

J B Quayle
PMCID: PMC2011084  PMID: 7150474

Abstract

The relationship of serum carcinoembryonic antigen (CEA) levels to tumour size and antigen content was studied in artificially immune-deprived mice bearing human colonic, breast and lung tumour xenografts. Size was measured as in vivo volume and tumour weight at post-mortem. A multiple implant technique combined with early harvest was used to minimize centrilobular tumour necrosis. CEA was extracted from resected tumours with perchloric acid. A radioimmunoassay using chemical precipitation was used to estimate CEA in blood samples. A correlation was found between CEA blood levels and tumour size in half the tumour lines, in contrast to a recent report (Lewis & Keep, 1981). The CEA content was found to be constant for one tumour line but not another. The possibility that central necrosis in xenograft tumours may account for the discrepancies is discussed. There may be serious limitations for the use of xenograft tumour models for studying the biology of CEA.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borthwick N. M., Wilson D. W., Bell P. A. Carcinoembryonic antigen (CEA) in patients with breast cancer. Eur J Cancer. 1977 Feb;13(2):171–176. doi: 10.1016/0014-2964(77)90196-7. [DOI] [PubMed] [Google Scholar]
  2. Chu T. M., Nemoto T. Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst. 1973 Oct;51(4):1119–1122. doi: 10.1093/jnci/51.4.1119. [DOI] [PubMed] [Google Scholar]
  3. Cove D. H., Woods K. L., Smith S. C., Burnett D., Leonard J., Grieve R. J., Howell A. Tumour markers in breast cancer. Br J Cancer. 1979 Nov;40(5):710–718. doi: 10.1038/bjc.1979.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DiSaia P. J., Haverback B. J., Dyce B. J., Morrow C. P. Carcinoembryonic antigen in patients with gynecologic malignancies. Am J Obstet Gynecol. 1975 Jan 15;121(2):159–163. doi: 10.1016/0002-9378(75)90631-6. [DOI] [PubMed] [Google Scholar]
  5. DiSaia P. J., Morrow C. P., Haverback B. J., Dyce B. J. Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state. Cancer. 1977 Jun;39(6):2365–2370. doi: 10.1002/1097-0142(197706)39:6<2365::aid-cncr2820390609>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gropp C., Havemann K., Scheuer A. The use of carcinoembryonic antigen and peptide hormones to stage and monitor patients with lung cancer. Int J Radiat Oncol Biol Phys. 1980 Aug;6(8):1047–1053. doi: 10.1016/0360-3016(80)90116-9. [DOI] [PubMed] [Google Scholar]
  8. Jones B. R. OCULAR SYMPTOMS IN GLANDULAR FEVER. Br J Ophthalmol. 1957 Mar;41(3):191–191. doi: 10.1136/bjo.41.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Joyce S., Lobe T., Cooperman M., Martin E. W., Jr Direct carcinoembryonic antigen assay in diagnosis and prognosis. Surgery. 1979 Oct;86(4):627–631. [PubMed] [Google Scholar]
  10. Kameya T., Kuramoto H., Suzuki K., Kenjo T., Oshikiri T., Hayashi H., Itakura M. A human gastric choriocarcinoma cell line with human chorionic gonadotropin and placental alkaline phosphatase production. Cancer Res. 1975 Aug;35(8):2025–2032. [PubMed] [Google Scholar]
  11. Khoo S. K., MacKay E. V. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs. Br J Obstet Gynaecol. 1976 Oct;83(10):753–759. doi: 10.1111/j.1471-0528.1976.tb00739.x. [DOI] [PubMed] [Google Scholar]
  12. Khoo S. K., Warner N. L., Lie J. T., Mackay I. R. Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int J Cancer. 1973 May;11(3):681–687. doi: 10.1002/ijc.2910110319. [DOI] [PubMed] [Google Scholar]
  13. Khoo S. K., Whitaker S. V., Jones I. S., Mackay E. V. Carcinoembryonic antigen in patients with residual ovarian cancer. Clinical and pathological correlations. Gynecol Oncol. 1979 Jun;7(3):288–295. doi: 10.1016/0090-8258(79)90106-9. [DOI] [PubMed] [Google Scholar]
  14. Laurence D. J., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E. W., Neville A. M. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J. 1972 Sep 9;3(5827):605–609. doi: 10.1136/bmj.3.5827.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lewis J. C., Keep P. A. Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts. Br J Cancer. 1981 Sep;44(3):381–387. doi: 10.1038/bjc.1981.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mach J. P., Carrel S., Merenda C., Sordat B., Cerottini J. C. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature. 1974 Apr 19;248(5450):704–706. doi: 10.1038/248704a0. [DOI] [PubMed] [Google Scholar]
  17. Martin E. W., Jr, James K. K., Hurtubise P. E., Catalano P., Minton J. P. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures. Cancer. 1977 Feb;39(2):440–446. doi: 10.1002/1097-0142(197702)39:2<440::aid-cncr2820390212>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  18. Nowak K., Peckham M. J., Steel G. G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer. 1978 Apr;37(4):576–584. doi: 10.1038/bjc.1978.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Quayle J. B. Tumour lysis as a factor affecting blood levels of CEA. Br J Cancer. 1982 Aug;46(2):213–219. doi: 10.1038/bjc.1982.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Raghavan D., Gibbs J., Nogueira Costa R., Kohn J., Orr A. H., Barrett A., Peckham M. J. The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl. 1980 Apr;4:191–194. [PMC free article] [PubMed] [Google Scholar]
  21. Stevens U., Laurence D. J., Ormerod M. G. Antibodies to lactalbumin interfere with its radioimmunoassay in human plasma. Clin Chim Acta. 1978 Jul 1;87(1):149–157. doi: 10.1016/0009-8981(78)90069-4. [DOI] [PubMed] [Google Scholar]
  22. Steward A. M., Nixon D., Zamcheck N., Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer. 1974 May;33(5):1246–1252. doi: 10.1002/1097-0142(197405)33:5<1246::aid-cncr2820330509>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  23. Stragand J. J., Yang L. Y., Drewinko B. Serum CEA levels in a human colonic adenocarcinoma (LOVO) xenograft system. Cancer Lett. 1980 Jul;10(1):45–50. doi: 10.1016/0304-3835(80)90064-6. [DOI] [PubMed] [Google Scholar]
  24. Thomas P., Hems D. A. The hepatic clearance of circulating native and asialo carcinoembronic antigen by the rat. Biochem Biophys Res Commun. 1975 Dec 1;67(3):1205–1209. doi: 10.1016/0006-291x(75)90801-3. [DOI] [PubMed] [Google Scholar]
  25. Vincent R. G., Chu T. M., Fergen T. B., Ostrander M. Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer. 1975 Dec;36(6):2069–2076. doi: 10.1002/cncr.2820360923. [DOI] [PubMed] [Google Scholar]
  26. Waalkes T. P., Abeloff M. D., Woo K. B., Ettinger D. S., Ruddon R. W., Aldenderfer P. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment. Cancer Res. 1980 Dec;40(12):4420–4427. [PubMed] [Google Scholar]
  27. Wanebo H. J. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery. 1981 Mar;89(3):290–295. [PubMed] [Google Scholar]
  28. Westwood J. H., Thomas P., Edwards R. G., Scopes P. M., Barrett M. W. Chemical modifications of the protein of carcinoembryonic antigen: associated changes in immunological activity and conformation. Br J Cancer. 1978 Feb;37(2):183–189. doi: 10.1038/bjc.1978.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Westwood J. H., Thomas P. Studies on the structure and immunological activity of carcinoembryonic antigen - the role of disulphide bonds. Br J Cancer. 1975 Dec;32(6):708–719. doi: 10.1038/bjc.1975.282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES